Search results
Moderna’s mRNA dreams meet reality with first post-COVID shot - The Boston Globe
The Boston Globe· 12 hours agoModerna’s stock dropped 45 percent last year, making it the worst-performing large biotech in the...
Moderna’s First Vaccine Was a Big Hit. Its Second Is a Let Down
Bloomberg via Yahoo Finance· 23 hours ago(Bloomberg) -- Moderna Inc.’s pioneering Covid shot turned the company into a nearly $200 billion...
Moderna loses less than expected as Covid vaccine sales beat estimates, cost cuts take hold
CNBC· 1 week agoModerna on Thursday posted a narrower-than-expected loss for the first quarter as the company's...
Moderna’s sales from its only product, the COVID-19 vaccine, fell 91% from last year
Fortune via Yahoo Finance· 1 week agoThose products could range from RSV vaccines to individualized cancer treatments, which will help...
Merck Reports Progress On The Cancer Front As It Prepares For Keytruda Patent Expiration
Benzinga· 1 week agoAfter topping expectations with first quarter revenue and adjusted earnings last week, Merck & Co...
Moderna beats estimates in Q1 2024, targets RSV vaccine launch in fall By Investing.com
Investing.com· 1 week agoModerna Inc. (NASDAQ:MRNA) reported first-quarter earnings and revenue that came ahead of analyst...
Moderna posts better-than-expected quarterly results as it looks to fall RSV vaccine launch
Market Watch· 1 week agoModerna Inc. on Thursday reported a narrower-than-expected first-quarter loss as the COVID vaccine...
Moderna (MRNA) Q1 2024 Earnings Call Transcript
Motley Fool via Yahoo Finance· 1 week agoYou can access the press release issued this morning as well as the slides that we'll be reviewing by going to the investor section of our website. On...
Tech Bytes: Moderna partners with OpenAI to expedite drug development processes
Proactive Investors· 3 days agoModerna, the biotechnology firm best known for its COVID-19 vaccines, has partnered with artificial...
Moderna COVID vaccine sales plummet 91 percent - The Boston Globe
The Boston Globe· 1 week agoSales of Moderna’s COVID-19 vaccine plunged 91 percent from the previous year for the first quarter...